Prosecutors say a Pennsylvania medical-equipment company submitted at least $1.3 billion in fraudulent claims to Medicare and other insurers over five months in 2025, but the money that actually left those insurers’ accounts was a fraction of that: about $6.5 million. The gap between the number in the indictment and the number that got paid isn’t a rounding error. It’s evidence of how much Medicare’s own fraud screening is doing quietly, and how much can still get through anyway.
The $1.3 Billion Figure Prosecutors Cited in the Indictment
A federal grand jury in Boston indicted Erekle Gugava, 33, a Georgian national, on September 3, 2026, on one count of conspiracy to launder money tied to health care fraud. Prosecutors say Gugava purportedly owned ND Medical Solutions LLC, a durable-medical-equipment company in Pennsylvania, from February through July 2025, and that during that window ND Medical submitted its claims to Medicare, to private insurers that sell Medicare supplemental policies, and to employer-sponsored and union health plans.
The claims relied, according to the charging documents, on the stolen identities of Americans, including elderly and disabled beneficiaries, to make the billing look legitimate. Gugava is accused of opening bank accounts in ND Medical’s name and moving reimbursement money that came in to accounts overseas, according to the Justice Department’s Office of Public Affairs.
Free retirement updates: Want plain-English help keeping more of your money in retirement? The free Retirement Shield newsletter covers the benefits, deadlines, and money mistakes that cost retirees, a couple times a week. Subscribe free.
What Insurers Actually Paid Before the Claims Were Caught
Of the $1.3 billion ND Medical billed, the indictment states that insurers, Medicare among them, paid the company approximately $6.5 million, according to the U.S. Attorney’s Office for the District of Massachusetts. That works out to roughly half of one percent of what was billed. Put another way, for every $200 in fraudulent claims prosecutors say ND Medical submitted, about $1 actually went out the door.
That ratio matters more than the $1.3 billion headline figure, because it’s the paid-out number, not the billed number, that reflects what premium-payers and taxpayers actually lost. A billed amount in a health care fraud indictment is what a defendant is accused of trying to take; a paid amount is what the system’s screening let through before catching the rest.
How Medicare’s Screening Systems Catch Billing Like This
ND Medical’s case is one piece of a larger investigation the Justice Department calls Operation Gold Rush, which it describes as the largest health care fraud case it has ever prosecuted. In the broader takedown announced in June 2025, prosecutors said the same Russia-based organization behind ND Medical submitted $10.6 billion in fraudulent claims nationwide for urinary catheters and other durable medical equipment, using the stolen identities of more than a million Americans.
The Justice Department credits its Health Care Fraud Unit’s data analytics team with flagging that anomalous billing pattern early enough that Medicare and HHS’s inspector general blocked all but about $41 million of the roughly $4.45 billion in claims that had been scheduled for direct Medicare payment. That kind of screening runs on a system CMS calls its Fraud Prevention System, which applies predictive models against Medicare’s fee-for-service claims before and after payment, flagging aberrant billing patterns and holding suspect claims automatically, according to CMS’s own description of the system. In the months before the June 2025 takedown, CMS also suspended or revoked the billing privileges of 205 providers as part of the same enforcement push.
The Pattern Holds Across the Larger Operation Gold Rush Case
Even with that screening in place, the wider scheme still produced about $900 million in payments, and nearly all of it came through Medicare supplemental insurers rather than Medicare’s own claims system. That split lines up with what happened at ND Medical: the claims routed through Medicare’s more centralized, automated review were blocked at a far higher rate than the ones routed through private-sector claims processing.
None of this is presented by the Justice Department as evidence that any private insurer did anything wrong; no insurer has been charged in the case. It’s simply the reason billed-versus-paid numbers diverge so sharply in prosecutions like this one, and why the $6.5 million figure, not the $1.3 billion figure, is the number that shows up anywhere in the case record as an actual loss.
Why the Screening Didn’t Stop Everything
Screening caught most of the money, but it didn’t stop the identity theft that made the claims look legitimate in the first place, and prosecutors say it didn’t stop Gugava from moving the $6.5 million that did get paid into overseas accounts before he left the United States in July 2025. Investigators say they have seized approximately $27.7 million in fraud proceeds across Operation Gold Rush to date, a figure that reflects the wider investigation and not ND Medical alone.
Gugava faces up to 20 years in prison and a fine of up to $500,000, or twice the amount laundered, if convicted; the Justice Department states that the charge is an allegation and that he is presumed innocent unless proven guilty in court. The case is being prosecuted by the department’s National Fraud Enforcement Division alongside the U.S. Attorney’s Office in Boston, the same team still working through the roughly $10.6 billion in claims Operation Gold Rush uncovered nationwide.
This article was produced with AI assistance and reviewed by a human editor. Figures are linked to their primary sources; where a claim could not be verified from the public record, we say so.
More Financial Reading
